Hepatitis C virus status is a factor in decisions about renal dialysis and transplantation, but liver disease is not a major cause of worse renal outcomes and should not preclude patients from appropriate treatment, an Australian study has found.
Dr Miriam Levy, from Liverpool Hospital in Sydney, and colleagues said there was a lack of data about the impact of HCV infection in end-stage renal disease. Existing reports about its effects before and after transplantation were inconsistent.
In a study reported in Transplantation, they examined 23,046 dialysis patients and 7572 renal transplant patients in the Australian and New Zealand Dialysis and Transplant (ANZDATA) registry. They were followed for a mean of just over five years.
There were 362 dialysis patients...
This site is intended for Registered Medical Practitioners.
To make the most of Gastroenterology Update, you need to be logged in.